Treatment and outcome of 66 patients with primary RT or primary chemotherapy*
Initial treatment, salvage therapy, and outcome . | n . |
|---|---|
| RT | 7 |
| Median age | 40 y |
| CR | 7 |
| NR | 0 |
| Relapse | |
| Local | 4 |
| Systemic | 0 |
| Median time from CR to relapse | 187 mo |
| Salvage treatment for patients with relapse | |
| CR | 2 |
| NR | 2 |
| Total no. of deaths | 2 |
| Anthracycline-containing regimen + RT consolidation | |
| CHOP | 25 |
| m-BACOD | 17 |
| ProMACE-CytaBOM | 5 |
| Median age | 42 y |
| CR | 31 |
| NR | 16 |
| Relapse | |
| Local | 8 |
| Systemic | 5 |
| Median time from CR to relapse | 100 mo |
| Salvage treatment for relapsed patients | |
| CR | 3 |
| PR | 1 |
| NR | 9 |
| Total no. of deaths | 23 |
| Nonanthracycline-containing regimen + RT consolidation | |
| COPP | 12 |
| Median age | 72 y |
| CR | 4 |
| NR | 8 |
| Relapse | |
| Local | 1 |
| Systemic | 0 |
| Median time from CR to relapse | 4 mo |
| Salvage treatment for patients with relapse | |
| CR | 0 |
| NR | 1 |
| Total no. of deaths | 9 |
Initial treatment, salvage therapy, and outcome . | n . |
|---|---|
| RT | 7 |
| Median age | 40 y |
| CR | 7 |
| NR | 0 |
| Relapse | |
| Local | 4 |
| Systemic | 0 |
| Median time from CR to relapse | 187 mo |
| Salvage treatment for patients with relapse | |
| CR | 2 |
| NR | 2 |
| Total no. of deaths | 2 |
| Anthracycline-containing regimen + RT consolidation | |
| CHOP | 25 |
| m-BACOD | 17 |
| ProMACE-CytaBOM | 5 |
| Median age | 42 y |
| CR | 31 |
| NR | 16 |
| Relapse | |
| Local | 8 |
| Systemic | 5 |
| Median time from CR to relapse | 100 mo |
| Salvage treatment for relapsed patients | |
| CR | 3 |
| PR | 1 |
| NR | 9 |
| Total no. of deaths | 23 |
| Nonanthracycline-containing regimen + RT consolidation | |
| COPP | 12 |
| Median age | 72 y |
| CR | 4 |
| NR | 8 |
| Relapse | |
| Local | 1 |
| Systemic | 0 |
| Median time from CR to relapse | 4 mo |
| Salvage treatment for patients with relapse | |
| CR | 0 |
| NR | 1 |
| Total no. of deaths | 9 |
CR indicates complete remission; PR, partial remission (> 50% reduction in tumor mass); NR, nonremission. The chemotherapy regimens are explained in Table 1.
Excluding one patient who achieved CR after initial treatment with surgery alone.